Skip to main content
. 2016 Jul 28;7(42):69014–69023. doi: 10.18632/oncotarget.10883

Figure 4. Serum levels of sCD40L.

Figure 4

Serum levels of sCD40L decreased significantly after treatment with Sm-153-EDTMP in combination with vaccine. Soluble CD40L in serum was measured by ELISA before and during therapy. (A) Patients treated with Sm-153-EDTMP alone. (B) Patients treated with Sm153-EDTMP and vaccine. Dot plots show results for individual patients, the median and the interquartile range. Wilcoxon signed rank test. **P = 0.0046.